Race, Ethnicity, and Ancestry in Clinical Pathways: A Framework for Evaluation

被引:2
|
作者
Rosen, Robert H. [1 ,2 ]
Epee-Bounya, Alexandra [1 ,2 ]
Curran, Dorothy [1 ,2 ]
Chung, Sarita [1 ,2 ]
Hoffmann, Robert [1 ,2 ]
Lee, Lois K. [1 ,2 ]
Marcus, Carolyn [1 ,2 ]
Mateo, Camila M. [1 ,2 ]
Miller, Jason E. [1 ]
Nereim, Cameron [1 ,2 ,3 ]
Silberholz, Elizabeth [1 ,2 ]
Shah, Snehal N. [1 ,2 ]
Theodoris, Christina V. [1 ,2 ]
Wardell, Hanna [1 ,2 ]
Winn, Ariel S. [1 ,2 ]
Toomey, Sara [1 ,2 ]
Finkelstein, Jonathan A. [4 ]
Ward, Valerie L. [1 ,2 ]
Starmer, Amy [1 ,2 ,5 ]
机构
[1] Boston Childrens Hosp, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Univ S Florida, Morsani Coll Med, Tampa, FL USA
[4] Kaiser Permanente Bernard J Tyson Sch Med, Pasadena, CA USA
[5] Baystate Childrens Hosp, Springfield, MA USA
关键词
NEONATAL HYPERBILIRUBINEMIA; HEMOGLOBIN A(1C); HEALTH; PREVENTION; BILIRUBIN; GLUCOSE; CATHETERIZATION; CHILDREN; INFANTS; OBESITY;
D O I
10.1542/peds.2022-060730
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Clinical algorithms, or "pathways," promote the delivery of medical care that is consistent and equitable. Race, ethnicity, and/or ancestry terms are sometimes included in these types of guidelines, but it is unclear if this is appropriate for clinical decision-making. At our institution, we developed and applied a structured framework to determine whether race, ethnicity, or ancestry terms identified in our clinical pathways library should be retained, modified, or removed. First, we reviewed all text and associated reference documents for 132 institutionally-developed clinical pathways and identified 8 pathways that included race, ethnicity, or ancestry terms. Five pathways had clear evidence or a change in institutional policy that supported removal of the term. Multispecialty teams conducted additional in-depth evaluation of the 3 remaining pathways (Acute Viral Illness, Hyperbilirubinemia, and Weight Management) by applying the framework. In total, based on these reviews, race, ethnicity, or ancestry terms were removed (n = 6) or modified (n = 2) in all 8 pathways. Application of the framework established several recommended practices, including: (1) define race, ethnicity, and ancestry rigorously; (2) assess the most likely mechanisms underlying epidemiologic associations; (3) consider whether inclusion of the term is likely to mitigate or exacerbate existing inequities; and (4) exercise caution when applying population-level data to individual patient encounters. This process and framework may be useful to other institutional programs and national organizations in evaluating the inclusion of race, ethnicity, and ancestry in clinical guidelines.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Life Course Offending Pathways Across Gender and Race/Ethnicity
    Broidy L.M.
    Stewart A.L.
    Thompson C.M.
    Chrzanowski A.
    Allard T.
    Dennison S.M.
    Journal of Developmental and Life-Course Criminology, 2015, 1 (2) : 118 - 149
  • [32] Online database of clinical algorithms with race and ethnicity
    Visweswaran, Shyam
    Sadhu, Eugene M.
    Morris, Michele M.
    Vis, Anushka R.
    Samayamuthu, Malarkodi Jebathilagam
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [33] Reporting race/ethnicity in epilepsy clinical trials
    Burneo, JG
    Martin, R
    EPILEPSY & BEHAVIOR, 2004, 5 (05) : 743 - 745
  • [34] Journey to the Start of Day: Ancestry, Ethnicity, and My Work as a Clinical Psychologist
    Stepakoff, Shanee
    WOMEN & THERAPY, 2010, 33 (3-4) : 348 - 364
  • [35] Guidance on use of race, ethnicity, and geographic origin as proxies for genetic ancestry groups in biomedical publications
    Feero, W. Gregory
    Steiner, Robert D.
    Slavotinek, Anne
    Faial, Tiago
    Bamshad, Michael J.
    Austin, Jehannine
    Korf, Bruce R.
    Flanagin, Annette
    Bibbins-Domingo, Kirsten
    NATURE GENETICS, 2024, 56 (04) : 555 - 556
  • [36] Guidance on use of race, ethnicity, and geographic origin as proxies for genetic ancestry groups in biomedical publications
    W. Gregory Feero
    Robert D. Steiner
    Anne Slavotinek
    Tiago Faial
    Michael J. Bamshad
    Jehannine Austin
    Bruce R. Korf
    Annette Flanagin
    Kirsten Bibbins-Domingo
    Nature Genetics, 2024, 56 : 555 - 556
  • [37] Guidance on Use of Race, Ethnicity, and Geographic Origin as Proxies for Genetic Ancestry Groups in Biomedical Publications
    Feero, W. Gregory
    Steiner, Robert D.
    Slavotinek, Anne
    Faial, Tiago
    Bamshad, Michael J.
    Austin, Jehannine
    Korf, Bruce R.
    Flanagin, Annette
    Bibbins-Domingo, Kirsten
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (15): : 1276 - 1278
  • [38] Evolving use of ancestry, ethnicity, and race in genetics research-A survey spanning seven decades
    Byeon, Yen Ji Julia
    Islamaj, Rezarta
    Yeganova, Lana
    Wilbur, W. John
    Lu, Zhiyong
    Brody, Lawrence C.
    Bonham, Vence L.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2021, 108 (12) : 2215 - 2223
  • [39] A Framework for Considering the Value of Race and Ethnicity in Estimating Disease Risk
    Coots, Madison
    Saghafian, Soroush
    Kent, David M.
    Goel, Sharad
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : 98 - +
  • [40] Guidance on use of race, ethnicity, and geographic origin as proxies for genetic ancestry groups in biomedical publications
    Feero, W. Gregory
    Steiner, Robert D.
    Slavotinek, Anne
    Faial, Tiago
    Bamshad, Michael J.
    Austin, Jehannine
    Korf, Bruce R.
    Flanagin, Annette
    Bibbins-Domingo, Kirsten
    AMERICAN JOURNAL OF HUMAN GENETICS, 2024, 111 (04) : 621 - 623